Liu X et al. [39] pointed out that miR-296-3p inhibits ICAM1 expression leading to tumor metastasis [42] Overall, this finding suggested that alterations of these genes/pathways represent meaningful risk factors in NSCLC. This evidence concerns the gene ICAM1 and non-small cell lung carcinoma.